Login to Your Account



Pharma: Clinic Roundup


Tuesday, June 26, 2012
• Novo Nordisk A/S, of Bagsvaerd, Denmark, reported data from a subgroup analysis of the A1chieve study showing that intensifying treatment with NovoMix 30 (Biphasic insulin aspart) can significantly improve blood glucose control in people with Type II diabetes who have reduced incidences of hypoglycemia.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription